Bolt Biotherapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BOLT Nasdaq 2834 www.boltbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2025 3:25 pm
Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot - May 12th, 2025 2:28 pm
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - May 12th, 2025 2:05 pm
Biotech Alert: Searches spiking for these stocks today - May 10th, 2025 9:55 am
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates - May 8th, 2025 6:00 am
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025 - Apr 30th, 2025 2:05 pm
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - Apr 25th, 2025 11:00 am
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - Mar 25th, 2025 2:30 pm
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - Mar 24th, 2025 2:37 pm
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - Mar 24th, 2025 2:20 pm
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Feb 25th, 2025 2:05 pm
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc. - Feb 11th, 2025 2:05 pm
Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations - Nov 15th, 2024 5:17 am
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates - Nov 12th, 2024 3:35 pm
Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot - Nov 12th, 2024 2:27 pm
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Nov 12th, 2024 2:05 pm
Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation - Nov 9th, 2024 7:49 am
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - Nov 7th, 2024 8:00 am
Bolt Biotherapeutics Announces Changes to its Board of Directors - Sep 4th, 2024 2:05 pm
Bolt Biotherapeutics to Participate in Upcoming September Conferences - Aug 28th, 2024 5:00 am